| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
337,799 |
264,226 |
$8.59M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
91,891 |
87,533 |
$3.04M |
| 0450 |
Emergency room services |
33,368 |
28,728 |
$2.44M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
64,595 |
61,845 |
$2.41M |
| 59425 |
|
30,897 |
24,908 |
$2.23M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
3,886 |
3,322 |
$1.65M |
| Z7500 |
|
41,577 |
37,114 |
$1.40M |
| Z7502 |
|
36,067 |
35,500 |
$1.35M |
| Q3014 |
Telehealth originating site facility fee |
42,870 |
38,964 |
$1.20M |
| G0390 |
Trauma response team associated with hospital critical care service |
481 |
448 |
$1.18M |
| J7307 |
Etonogestrel (contraceptive) implant system, including implant and supplies |
989 |
930 |
$1.17M |
| 0760 |
|
31,889 |
25,284 |
$881K |
| 76818 |
|
13,426 |
6,632 |
$796K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
11,762 |
11,603 |
$668K |
| J9271 |
Injection, pembrolizumab, 1 mg |
48 |
37 |
$661K |
| 0761 |
|
25,094 |
19,747 |
$577K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
9,483 |
9,143 |
$531K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,655 |
1,595 |
$459K |
| 90674 |
|
13,717 |
13,583 |
$429K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
12,631 |
6,827 |
$424K |
| 90739 |
|
3,191 |
3,135 |
$421K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
16,617 |
15,204 |
$409K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
16,610 |
15,198 |
$407K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
6,534 |
6,482 |
$403K |
| 90715 |
|
11,752 |
10,989 |
$396K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
6,617 |
6,305 |
$385K |
| 90651 |
|
3,627 |
3,594 |
$376K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14,274 |
13,621 |
$366K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
6,413 |
5,695 |
$359K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
3,874 |
3,835 |
$291K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
776 |
772 |
$289K |
| J3490 |
Unclassified drugs |
15,515 |
8,307 |
$270K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
11,156 |
11,067 |
$257K |
| 80053 |
Comprehensive metabolic panel |
29,122 |
24,381 |
$244K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,272 |
2,330 |
$241K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
39,107 |
32,746 |
$232K |
| 0360 |
|
1,355 |
742 |
$229K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,805 |
2,750 |
$224K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
6,063 |
4,717 |
$224K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
6,860 |
3,219 |
$221K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
10,801 |
9,861 |
$220K |
| 90677 |
|
2,130 |
2,059 |
$213K |
| 90732 |
|
1,564 |
1,293 |
$207K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,699 |
1,617 |
$207K |
| 99205 |
Prolong outpt/office vis |
1,537 |
1,506 |
$202K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
4,107 |
3,247 |
$193K |
| 90686 |
|
13,073 |
10,243 |
$190K |
| 90791 |
Psychiatric diagnostic evaluation |
1,211 |
1,179 |
$185K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
2,120 |
1,966 |
$177K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
8,676 |
8,568 |
$171K |
| 90670 |
|
10,998 |
10,629 |
$168K |
| 84443 |
Thyroid stimulating hormone (TSH) |
13,481 |
12,154 |
$164K |
| 96127 |
|
23,575 |
22,798 |
$160K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
7,987 |
7,287 |
$157K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
6,882 |
6,250 |
$155K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
2,277 |
2,220 |
$152K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
2,464 |
1,849 |
$141K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
2,866 |
2,762 |
$141K |
| 71046 |
Radiologic examination, chest; 2 views |
8,036 |
7,551 |
$137K |
| 86480 |
|
4,064 |
3,768 |
$130K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
598 |
569 |
$127K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
637 |
604 |
$119K |
| 92551 |
|
11,184 |
11,093 |
$116K |
| 80061 |
Lipid panel |
12,150 |
11,278 |
$116K |
| 90837 |
Psychotherapy, 53 minutes with patient |
1,379 |
987 |
$113K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
15,688 |
14,374 |
$110K |
| 59430 |
|
1,395 |
1,350 |
$109K |
| 96415 |
|
2,147 |
1,246 |
$103K |
| 0510 |
|
4,510 |
4,131 |
$99K |
| 99173 |
|
21,848 |
21,440 |
$99K |
| 86331 |
|
6,465 |
5,876 |
$97K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,062 |
1,026 |
$96K |
| Z7610 |
|
13,668 |
8,949 |
$96K |
| 99606 |
|
4,195 |
3,887 |
$94K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,178 |
3,837 |
$92K |
| 99215 |
Prolong outpt/office vis |
2,445 |
2,352 |
$88K |
| 0270 |
|
10,569 |
6,146 |
$88K |
| 86171 |
|
6,449 |
5,860 |
$86K |
| 0002A |
|
1,998 |
1,998 |
$78K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
689 |
672 |
$78K |
| 99381 |
|
1,262 |
1,233 |
$76K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,635 |
9,968 |
$76K |
| 96417 |
|
1,947 |
963 |
$72K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,156 |
4,488 |
$71K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
4,552 |
4,183 |
$71K |
| 90680 |
|
7,462 |
7,147 |
$69K |
| 81002 |
|
28,606 |
19,421 |
$69K |
| 99385 |
|
517 |
504 |
$66K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,514 |
1,292 |
$65K |
| 0001A |
|
1,764 |
1,764 |
$64K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,158 |
1,145 |
$63K |
| 71045 |
Radiologic examination, chest; single view |
3,961 |
3,632 |
$62K |
| 84439 |
|
9,110 |
8,129 |
$60K |
| 80074 |
|
1,711 |
1,523 |
$60K |
| 90633 |
|
6,458 |
6,348 |
$60K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
941 |
911 |
$57K |
| J0561 |
Injection, penicillin g benzathine, 100,000 units |
139 |
81 |
$56K |
| 90647 |
|
5,884 |
5,643 |
$54K |
| 90710 |
|
5,768 |
5,688 |
$54K |
| 81001 |
|
19,091 |
17,150 |
$53K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
552 |
530 |
$52K |
| 73130 |
|
2,591 |
1,630 |
$51K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,681 |
7,587 |
$51K |
| 81025 |
|
13,637 |
12,963 |
$51K |
| 90750 |
|
269 |
264 |
$50K |
| 99607 |
|
2,273 |
2,125 |
$50K |
| 90723 |
|
5,236 |
4,923 |
$48K |
| 72100 |
|
2,196 |
2,018 |
$47K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
6,150 |
3,537 |
$46K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,244 |
873 |
$46K |
| 83735 |
|
8,896 |
5,712 |
$46K |
| 0710 |
|
1,328 |
1,212 |
$45K |
| 90697 |
|
4,647 |
4,590 |
$42K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
343 |
337 |
$42K |
| 96156 |
|
487 |
487 |
$41K |
| 99188 |
|
1,773 |
1,755 |
$38K |
| 90734 |
|
3,717 |
3,697 |
$37K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
303 |
282 |
$36K |
| J7298 |
Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg |
27 |
27 |
$35K |
| 73030 |
|
1,816 |
1,477 |
$35K |
| 73110 |
|
2,000 |
1,251 |
$34K |
| 86780 |
|
3,967 |
3,385 |
$34K |
| 96523 |
|
1,270 |
1,197 |
$33K |
| 80076 |
|
5,867 |
5,176 |
$33K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
576 |
570 |
$31K |
| 73562 |
|
1,590 |
1,313 |
$30K |
| 84100 |
|
8,188 |
5,430 |
$29K |
| 73630 |
|
1,673 |
1,219 |
$29K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
722 |
412 |
$29K |
| 90746 |
|
328 |
320 |
$29K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
314 |
312 |
$28K |
| Q0166 |
Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen |
3,870 |
1,584 |
$28K |
| 73610 |
|
1,458 |
1,091 |
$26K |
| 99199 |
Unlisted special service, procedure or report |
466 |
410 |
$25K |
| 90649 |
|
2,461 |
2,449 |
$25K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,471 |
4,088 |
$25K |
| 82607 |
|
2,339 |
2,099 |
$24K |
| 99383 |
|
270 |
266 |
$23K |
| 0250 |
|
1,194 |
659 |
$23K |
| 90700 |
|
2,541 |
2,505 |
$23K |
| 90834 |
Psychotherapy, 45 minutes with patient |
273 |
230 |
$23K |
| 83690 |
|
4,147 |
3,871 |
$23K |
| 87081 |
|
4,844 |
4,378 |
$22K |
| 90696 |
|
2,400 |
2,388 |
$22K |
| 85730 |
|
4,730 |
4,355 |
$22K |
| 59025 |
Fetal non-stress test |
1,307 |
840 |
$22K |
| 92552 |
|
1,705 |
1,695 |
$22K |
| 0514 |
|
915 |
829 |
$21K |
| 82043 |
|
5,172 |
4,675 |
$21K |
| 82570 |
|
5,607 |
5,028 |
$21K |
| 80050 |
General health panel |
237 |
237 |
$20K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
332 |
328 |
$20K |
| 73560 |
|
1,417 |
865 |
$20K |
| 92228 |
|
1,286 |
1,282 |
$19K |
| 99244 |
Office or other outpatient consultation, moderate to high complexity |
233 |
233 |
$19K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,737 |
1,702 |
$19K |
| 86235 |
|
1,420 |
1,156 |
$19K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
64 |
59 |
$19K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
826 |
813 |
$19K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
400 |
293 |
$19K |
| 85027 |
|
3,942 |
3,308 |
$19K |
| 86140 |
|
4,843 |
4,237 |
$18K |
| 85610 |
|
5,863 |
5,087 |
$18K |
| 90620 |
|
1,876 |
1,865 |
$18K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
2,545 |
2,073 |
$18K |
| 87186 |
|
2,928 |
2,527 |
$18K |
| 99243 |
|
345 |
344 |
$18K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
2,745 |
1,356 |
$18K |
| 0004A |
|
442 |
442 |
$18K |
| J2315 |
Injection, naltrexone, depot form, 1 mg |
27 |
27 |
$17K |
| 83520 |
|
1,728 |
1,452 |
$17K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
9,949 |
9,866 |
$17K |
| 86803 |
|
1,572 |
1,503 |
$16K |
| 82378 |
|
1,159 |
817 |
$16K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
1,760 |
1,585 |
$15K |
| 87340 |
|
1,941 |
1,725 |
$15K |
| 90662 |
|
224 |
168 |
$15K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1,385 |
1,363 |
$15K |
| 82728 |
|
1,518 |
1,323 |
$14K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
2,440 |
2,193 |
$14K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,874 |
2,580 |
$14K |
| 72040 |
|
777 |
689 |
$14K |
| 99070 |
|
26,563 |
11,207 |
$14K |
| 86850 |
|
3,259 |
2,914 |
$14K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,736 |
1,292 |
$13K |
| 83655 |
|
1,728 |
1,610 |
$13K |
| 84702 |
|
1,216 |
930 |
$13K |
| 96367 |
|
303 |
181 |
$12K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,660 |
1,889 |
$12K |
| 88720 |
|
2,649 |
2,215 |
$12K |
| 84484 |
|
1,493 |
1,336 |
$12K |
| 86255 |
|
1,344 |
1,095 |
$12K |
| 86901 |
|
3,743 |
3,336 |
$12K |
| J7050 |
Infusion, normal saline solution, 250 cc |
2,111 |
1,285 |
$12K |
| 86762 |
|
999 |
897 |
$12K |
| 87077 |
|
1,955 |
1,810 |
$11K |
| 85652 |
|
5,520 |
4,765 |
$11K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
643 |
588 |
$11K |
| 96376 |
|
244 |
211 |
$11K |
| 83880 |
|
473 |
439 |
$11K |
| 86038 |
|
3,290 |
2,808 |
$10K |
| 76830 |
Ultrasound, transvaginal |
190 |
185 |
$10K |
| 82948 |
|
2,900 |
2,477 |
$10K |
| 0054A |
|
256 |
256 |
$10K |
| 11981 |
|
415 |
402 |
$10K |
| 58100 |
|
350 |
347 |
$9K |
| 88307 |
|
200 |
200 |
$9K |
| 99384 |
|
93 |
90 |
$9K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
646 |
596 |
$9K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
1,362 |
1,184 |
$9K |
| 85018 |
|
7,258 |
6,895 |
$9K |
| 76770 |
|
128 |
126 |
$8K |
| 86160 |
|
770 |
604 |
$8K |
| 74018 |
|
482 |
442 |
$8K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
228 |
227 |
$8K |
| 81003 |
|
3,954 |
3,590 |
$8K |
| 86900 |
|
2,635 |
2,473 |
$8K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
1,365 |
1,241 |
$7K |
| 83970 |
|
253 |
237 |
$7K |
| 83540 |
|
1,508 |
1,328 |
$7K |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
1,363 |
1,193 |
$7K |
| 84153 |
|
713 |
660 |
$7K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
479 |
432 |
$7K |
| 87070 |
|
989 |
935 |
$7K |
| 83550 |
|
1,166 |
1,039 |
$7K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
211 |
206 |
$6K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
112 |
106 |
$6K |
| 84703 |
|
1,171 |
1,019 |
$6K |
| 0072A |
|
153 |
153 |
$6K |
| 87210 |
|
1,954 |
1,910 |
$6K |
| 97802 |
|
229 |
200 |
$6K |
| 86431 |
|
1,451 |
1,221 |
$6K |
| 90678 |
|
54 |
54 |
$6K |
| 83605 |
|
665 |
602 |
$6K |
| 0052A |
|
143 |
143 |
$6K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
278 |
254 |
$5K |
| 72170 |
|
286 |
233 |
$5K |
| 90672 |
|
590 |
590 |
$5K |
| 0071A |
|
129 |
129 |
$5K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
537 |
427 |
$5K |
| 73120 |
|
393 |
220 |
$5K |
| 90656 |
|
536 |
522 |
$5K |
| 86317 |
|
924 |
921 |
$5K |
| 82950 |
|
1,285 |
1,068 |
$5K |
| 90694 |
|
61 |
61 |
$5K |
| 86162 |
|
640 |
501 |
$5K |
| J2704 |
Injection, propofol, 10 mg |
831 |
772 |
$4K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
298 |
270 |
$4K |
| 11982 |
|
188 |
186 |
$4K |
| 73590 |
|
184 |
152 |
$4K |
| 82247 |
|
940 |
736 |
$4K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
804 |
759 |
$4K |
| 57454 |
|
129 |
128 |
$4K |
| 73090 |
|
149 |
125 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
468 |
290 |
$4K |
| 86704 |
|
673 |
633 |
$4K |
| 87088 |
|
814 |
587 |
$4K |
| G0442 |
Annual alcohol misuse screening, 5 to 15 minutes |
286 |
273 |
$4K |
| J9045 |
Injection, carboplatin, 50 mg |
210 |
109 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
439 |
432 |
$4K |
| 84999 |
|
390 |
351 |
$4K |
| H2000 |
Comprehensive multidisciplinary evaluation |
42 |
42 |
$4K |
| 72070 |
|
172 |
166 |
$4K |
| 99386 |
|
26 |
26 |
$4K |
| J9267 |
Injection, paclitaxel, 1 mg |
282 |
110 |
$3K |
| 90480 |
|
86 |
86 |
$3K |
| 73502 |
|
129 |
113 |
$3K |
| 76536 |
|
62 |
61 |
$3K |
| 86592 |
|
1,412 |
1,350 |
$3K |
| 72202 |
|
140 |
113 |
$3K |
| J3420 |
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg |
690 |
472 |
$3K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
75 |
16 |
$3K |
| 82785 |
|
244 |
184 |
$3K |
| 76641 |
|
43 |
40 |
$3K |
| G0500 |
Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) |
59 |
58 |
$3K |
| 87338 |
|
274 |
241 |
$3K |
| 0320 |
|
86 |
81 |
$3K |
| 82550 |
|
520 |
423 |
$2K |
| 86146 |
|
121 |
92 |
$2K |
| 58300 |
|
137 |
137 |
$2K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
407 |
382 |
$2K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
15 |
13 |
$2K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
39 |
39 |
$2K |
| 86021 |
|
153 |
120 |
$2K |
| 90707 |
|
191 |
189 |
$2K |
| 86376 |
|
266 |
195 |
$2K |
| 0051A |
|
54 |
54 |
$2K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
3,277 |
3,262 |
$2K |
| P9011 |
Blood, split unit |
745 |
567 |
$2K |
| 84550 |
|
682 |
586 |
$2K |
| 87522 |
Neg quan hep c or qual rna |
99 |
98 |
$2K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
93 |
89 |
$2K |
| 86706 |
|
475 |
407 |
$2K |
| 73080 |
|
99 |
89 |
$2K |
| G0108 |
Diabetes outpatient self-management training services, individual, per 30 minutes |
91 |
86 |
$2K |
| 86708 |
|
317 |
315 |
$2K |
| 90716 |
|
196 |
193 |
$2K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
292 |
84 |
$2K |
| 92134 |
|
87 |
87 |
$2K |
| 92015 |
Determination of refractive state |
76 |
76 |
$2K |
| 83615 |
|
440 |
340 |
$2K |
| 90681 |
|
204 |
191 |
$2K |
| 86003 |
|
384 |
284 |
$2K |
| Z7506 |
|
12 |
12 |
$2K |
| 87536 |
|
27 |
26 |
$2K |
| 83525 |
|
260 |
260 |
$2K |
| 82105 |
|
164 |
155 |
$2K |
| 86147 |
|
120 |
91 |
$2K |
| 86300 |
|
176 |
133 |
$2K |
| 76642 |
|
30 |
30 |
$2K |
| 90380 |
|
193 |
178 |
$2K |
| 91320 |
|
12 |
12 |
$2K |
| 80299 |
|
124 |
110 |
$2K |
| 96368 |
|
79 |
48 |
$1K |
| 99605 |
|
58 |
58 |
$1K |
| 84480 |
|
289 |
266 |
$1K |
| 87205 |
|
500 |
395 |
$1K |
| A4217 |
Sterile water/saline, 500 ml |
208 |
186 |
$1K |
| 73100 |
|
102 |
55 |
$1K |
| 0517 |
|
51 |
43 |
$1K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
35 |
35 |
$1K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
14 |
12 |
$1K |
| 69209 |
|
81 |
80 |
$1K |
| H1001 |
Prenatal care, at-risk enhanced service; antepartum management |
41 |
34 |
$1K |
| 0515 |
|
52 |
47 |
$1K |
| 12001 |
|
53 |
53 |
$1K |
| 58301 |
|
49 |
48 |
$1K |
| 82248 |
|
399 |
296 |
$1K |
| 83001 |
|
82 |
72 |
$1K |
| 86812 |
|
84 |
55 |
$1K |
| 90381 |
|
137 |
121 |
$1K |
| 71020 |
|
39 |
26 |
$1K |
| 0124A |
|
26 |
26 |
$1K |
| 85613 |
|
116 |
89 |
$970.01 |
| 93971 |
|
28 |
25 |
$953.21 |
| 82746 |
|
88 |
76 |
$952.66 |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
29 |
26 |
$946.52 |
| 82270 |
|
372 |
338 |
$894.12 |
| 76801 |
|
40 |
38 |
$892.20 |
| 90660 |
|
98 |
98 |
$882.00 |
| 97803 |
|
167 |
167 |
$846.51 |
| 82951 |
|
93 |
88 |
$835.10 |
| 99401 |
|
45 |
45 |
$794.25 |
| 72072 |
|
34 |
28 |
$770.71 |
| 84403 |
|
134 |
111 |
$765.00 |
| 99153 |
Mod sedat endo service >5yrs |
63 |
60 |
$763.23 |
| Z7512 |
|
25 |
24 |
$653.25 |
| 86360 |
|
26 |
25 |
$650.00 |
| 99382 |
|
12 |
12 |
$648.01 |
| 86039 |
|
102 |
98 |
$644.36 |
| 82274 |
|
55 |
55 |
$640.74 |
| 82784 |
|
110 |
91 |
$635.52 |
| 72046 |
|
33 |
33 |
$628.65 |
| 12011 |
|
18 |
18 |
$612.02 |
| 0064A |
|
15 |
15 |
$600.00 |
| 99241 |
|
15 |
15 |
$589.54 |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
13 |
12 |
$555.76 |
| H1003 |
Prenatal care, at-risk enhanced service; education |
68 |
67 |
$551.64 |
| 90685 |
|
305 |
303 |
$527.31 |
| 83002 |
|
39 |
39 |
$525.42 |
| 82150 |
|
110 |
101 |
$507.12 |
| 84154 |
|
169 |
166 |
$482.69 |
| 96150 |
|
59 |
57 |
$470.56 |
| Z6400 |
|
39 |
39 |
$470.34 |
| 90648 |
|
52 |
48 |
$468.00 |
| 86705 |
|
52 |
52 |
$454.39 |
| J2060 |
Injection, lorazepam, 2 mg |
113 |
104 |
$452.11 |
| 84146 |
|
31 |
27 |
$439.55 |
| 10060 |
|
45 |
41 |
$426.05 |
| 96411 |
|
32 |
12 |
$401.46 |
| 86200 |
|
60 |
60 |
$399.17 |
| 99233 |
Prolong inpt eval add15 m |
66 |
24 |
$386.41 |
| 12002 |
|
12 |
12 |
$371.97 |
| 76870 |
|
13 |
12 |
$365.76 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
27 |
27 |
$361.26 |
| 84481 |
|
69 |
66 |
$347.76 |
| 99201 |
|
14 |
14 |
$333.72 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
167 |
147 |
$319.16 |
| 82977 |
|
138 |
111 |
$311.18 |
| 83516 |
|
38 |
24 |
$293.64 |
| 86580 |
|
63 |
60 |
$292.63 |
| 86695 |
|
38 |
25 |
$288.22 |
| 86696 |
|
38 |
25 |
$288.22 |
| V5008 |
Hearing screening |
13 |
13 |
$285.54 |
| 87625 |
|
14 |
14 |
$285.02 |
| 17110 |
|
13 |
12 |
$281.60 |
| 88142 |
|
84 |
84 |
$277.32 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
377 |
332 |
$268.16 |
| 86304 |
|
34 |
27 |
$264.00 |
| 90713 |
|
28 |
28 |
$252.00 |
| 84156 |
|
101 |
89 |
$231.79 |
| 86800 |
|
46 |
42 |
$225.31 |
| 82952 |
|
76 |
72 |
$210.22 |
| 81000 |
|
181 |
178 |
$204.07 |
| 11983 |
|
12 |
12 |
$201.60 |
| 99001 |
|
150 |
146 |
$200.07 |
| 73000 |
|
12 |
12 |
$189.68 |
| 29125 |
|
13 |
13 |
$189.60 |
| 86403 |
|
18 |
18 |
$184.60 |
| 86671 |
|
13 |
12 |
$174.09 |
| 87902 |
|
13 |
13 |
$160.00 |
| J2175 |
Injection, meperidine hydrochloride, per 100 mg |
15 |
12 |
$159.85 |
| 88304 |
|
13 |
12 |
$159.84 |
| 84436 |
|
35 |
29 |
$154.00 |
| 90473 |
|
526 |
526 |
$153.00 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
23 |
12 |
$137.33 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
51 |
44 |
$120.78 |
| 90744 |
|
13 |
13 |
$117.00 |
| 84402 |
|
17 |
13 |
$102.00 |
| 84165 |
|
19 |
12 |
$98.56 |
| 82272 |
|
59 |
58 |
$88.06 |
| 80143 |
|
12 |
12 |
$86.78 |
| 85014 |
|
41 |
39 |
$85.35 |
| 87040 |
|
16 |
14 |
$76.42 |
| 94060 |
|
12 |
12 |
$62.02 |
| 82010 |
|
13 |
12 |
$54.61 |
| 88312 |
|
13 |
13 |
$52.52 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
15 |
14 |
$47.26 |
| 82565 |
|
13 |
12 |
$40.86 |
| 87147 |
|
12 |
12 |
$28.82 |
| 3079F |
|
3,466 |
3,294 |
$0.00 |
| 3074F |
|
6,026 |
5,623 |
$0.00 |
| 3075F |
|
1,302 |
1,236 |
$0.00 |
| 0370 |
|
20 |
12 |
$0.00 |
| 90673 |
|
124 |
122 |
$0.00 |
| 3080F |
|
30 |
29 |
$0.00 |
| 2023F |
|
27 |
27 |
$0.00 |
| G9008 |
Coordinated care fee, physician coordinated care oversight services |
27 |
27 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
13 |
13 |
$0.00 |
| 3078F |
|
5,476 |
5,075 |
$0.00 |
| H1002 |
Prenatal care, at risk enhanced service; care coordination |
37 |
37 |
$0.00 |
| 3077F |
|
797 |
738 |
$0.00 |
| 80361 |
|
555 |
373 |
$0.00 |
| J1750 |
Injection, iron dextran, 50 mg |
26 |
26 |
$0.00 |
| 92133 |
|
13 |
13 |
$0.00 |
| 90661 |
|
12 |
12 |
$0.00 |